|
Volumn 25, Issue , 1996, Pages 1-14
|
Risk biomarkers and current strategies for cancer chemoprevention.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
ANIMAL;
CHEMOPROPHYLAXIS;
COHORT ANALYSIS;
GENETICS;
HUMAN;
METHODOLOGY;
NEOPLASM;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
REVIEW;
RISK FACTOR;
ANIMALS;
ANTICARCINOGENIC AGENTS;
CHEMOPREVENTION;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
COHORT STUDIES;
HUMANS;
NEOPLASMS;
RESEARCH DESIGN;
RISK FACTORS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0030344875
PISSN: 07331959
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (77)
|
References (73)
|